Jushi Holdings (JUSHF) Shares Outstanding (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Shares Outstanding (Entity) of $199.7 million for Q2 2026, up 1.53% year-over-year from $196.7 million in Q2 2025, and little changed quarter-over-quarter from $199.7 million in Q1 2026.
Jushi Holdings (JUSHF) Shares Outstanding (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Shares Outstanding (Entity) for 6 consecutive years, with $199.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 1.53% year-over-year to $199.7 million; the TTM figure through Jun 2026 stood at $199.7 million (up 1.53% YoY), while the FY2025 annual figure was $199.7 million, up 1.53% from the prior year.
- Shares Outstanding (Entity) was little changed at $199.7 million in Q2 2026 per JUSHF's latest filing, from $199.7 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $199.7 million in Q2 2026 and bottomed at $189.7 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $196.6 million across 5 years, with a median of $196.7 million in 2022.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 28.0% — and 2023, when it retreated 0.03%.
- Jushi Holdings' Shares Outstanding (Entity) stood at $196.7 million in 2022, then decreased by 0.03% to $196.6 million in 2023, then gained by 0.03% to $196.7 million in 2024, then gained by 1.53% to $199.7 million in 2025, then gained by 0.0% to $199.7 million in 2026.
- Business Quant data shows JUSHF's Shares Outstanding (Entity) at $199.7 million in Q2 2026, $199.7 million in Q1 2026, and $199.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 198.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 198.20 Mn |
| Mar 31, 2026 | 198.16 Mn |
| Dec 31, 2025 | 195.20 Mn |
| Sep 30, 2025 | 195.20 Mn |
| Jun 30, 2025 | 195.20 Mn |
| Mar 31, 2025 | 195.20 Mn |
| Dec 31, 2024 | 195.16 Mn |
| Sep 30, 2024 | 195.17 Mn |
| Jun 30, 2024 | 195.14 Mn |
| Mar 31, 2024 | 195.13 Mn |
| Dec 31, 2023 | 194.77 Mn |
| Sep 30, 2023 | 195.13 Mn |
| Jun 30, 2023 | 194.76 Mn |
| Mar 31, 2023 | 194.05 Mn |
| Dec 31, 2022 | 190.02 Mn |
| Sep 30, 2022 | 192.88 Mn |
| Jun 30, 2022 | 190.87 Mn |
| Mar 31, 2022 | 183.23 Mn |
| Dec 31, 2021 | 170.29 Mn |
| Sep 30, 2021 | 168.80 Mn |